Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ABBOTT LABORATORIESABT · Entity 2314 | Executive Vice President | April 23, 2019 | April 24, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ABBOTT LABORATORIES
Report date April 23, 2019 · Filed April 24, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common shares without par valueSEC Table I · non-derivative | Direct | 169,935 |
Ending reported balance
After 2019-04-23 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2019-04-23 · Exercise / conversion · Acquired 56,000 · Balance 225,935 Row 2 · 2019-04-23 · Sale · Disposed 56,000 · Balance 169,935 |
| Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $47.00 · Expires 2025-02-19 | Direct | 113,227 |
Reported balance
After 2019-04-23 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2019-04-23 · Exercise / conversion · Disposed 56,000 · Balance 113,227 F3: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3. |
| Common shares without par valueSEC Table I · non-derivative | IndirectProfit Sharing Trust | 1,698 |
Reported balance
Holding disclosure · report date 2019-04-23 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 1,698 F1: Balance in the Abbott Laboratories Stock Retirement Trust as of April 23, 2019. |
| Common shares without par valueSEC Table I · non-derivative | IndirectBy Spouse | 53 |
Reported balance
Holding disclosure · report date 2019-04-23 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 53 F2: The reporting person disclaims beneficial ownership of all securities held by his spouse. |
Filing footnotes · ownership attribution and instrument terms
F1: Balance in the Abbott Laboratories Stock Retirement Trust as of April 23, 2019.
F2: The reporting person disclaims beneficial ownership of all securities held by his spouse.
F3: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 18, 2009 Filed Nov 19, 2009 23:38 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 6,597 | $43.00 | $283,671.00 |
DisclosureSEC source: 0001179110-09-015747 · edgar.xml · nonDerivative · entry 2 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,918 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Amount is subject to adjustment pursuant to a domestic relations order. Read SEC document |
| November 18, 2009 Filed Nov 19, 2009 23:38 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 5,321 | $48.33 | $257,163.93 |
DisclosureSEC source: 0001179110-09-015747 · edgar.xml · nonDerivative · entry 1 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,321 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Amount is subject to adjustment pursuant to a domestic relations order. Read SEC document |
| October 20, 2009 Filed Oct 22, 2009 21:08 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 277 | $51.81 | $14,351.90 |
DisclosureSEC source: 0001179110-09-014711 · edgar.xml · nonDerivative · entry 3 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,000 F1 · balance_after: Amount is subject to adjustment pursuant to a domestic relations order. Read SEC document |
| October 20, 2009 Filed Oct 22, 2009 21:08 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 1,800 | $51.81 | $93,259.80 |
DisclosureSEC source: 0001179110-09-014711 · edgar.xml · nonDerivative · entry 2 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,277 F1 · balance_after: Amount is subject to adjustment pursuant to a domestic relations order. Read SEC document |
| October 20, 2009 Filed Oct 22, 2009 21:08 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 900 | $51.81 | $46,630.80 |
DisclosureSEC source: 0001179110-09-014711 · edgar.xml · nonDerivative · entry 1 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,077 F1 · balance_after: Amount is subject to adjustment pursuant to a domestic relations order. Read SEC document |
| March 03, 2009 Filed Mar 5, 2009 22:00 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 500 | $46.28 | $23,140.00 |
DisclosureSEC source: 0001104659-09-014711 · a4.xml · nonDerivative · entry 12 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,977 F1 · balance_after: Amount is subject to adjustment pursuant to a domestic relations order. Read SEC document |
| March 03, 2009 Filed Mar 5, 2009 22:00 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 100 | $46.27 | $4,627.06 |
DisclosureSEC source: 0001104659-09-014711 · a4.xml · nonDerivative · entry 11 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,477 F1 · balance_after: Amount is subject to adjustment pursuant to a domestic relations order. Read SEC document |
| March 03, 2009 Filed Mar 5, 2009 22:00 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 200 | $46.27 | $9,254.10 |
DisclosureSEC source: 0001104659-09-014711 · a4.xml · nonDerivative · entry 10 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,577 F1 · balance_after: Amount is subject to adjustment pursuant to a domestic relations order. Read SEC document |
| March 03, 2009 Filed Mar 5, 2009 22:00 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 200 | $46.27 | $9,254.08 |
DisclosureSEC source: 0001104659-09-014711 · a4.xml · nonDerivative · entry 9 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,777 F1 · balance_after: Amount is subject to adjustment pursuant to a domestic relations order. Read SEC document |
| March 03, 2009 Filed Mar 5, 2009 22:00 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 200 | $46.27 | $9,254.04 |
DisclosureSEC source: 0001104659-09-014711 · a4.xml · nonDerivative · entry 8 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,977 F1 · balance_after: Amount is subject to adjustment pursuant to a domestic relations order. Read SEC document |
| March 03, 2009 Filed Mar 5, 2009 22:00 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 100 | $46.27 | $4,627.01 |
DisclosureSEC source: 0001104659-09-014711 · a4.xml · nonDerivative · entry 7 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,177 F1 · balance_after: Amount is subject to adjustment pursuant to a domestic relations order. Read SEC document |
| March 03, 2009 Filed Mar 5, 2009 22:00 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 700 | $46.27 | $32,389.00 |
DisclosureSEC source: 0001104659-09-014711 · a4.xml · nonDerivative · entry 6 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,277 F1 · balance_after: Amount is subject to adjustment pursuant to a domestic relations order. Read SEC document |
| March 03, 2009 Filed Mar 5, 2009 22:00 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 118 | $46.27 | $5,459.27 |
DisclosureSEC source: 0001104659-09-014711 · a4.xml · nonDerivative · entry 5 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,977 F1 · balance_after: Amount is subject to adjustment pursuant to a domestic relations order. Read SEC document |
| March 03, 2009 Filed Mar 5, 2009 22:00 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 800 | $46.26 | $37,008.00 |
DisclosureSEC source: 0001104659-09-014711 · a4.xml · nonDerivative · entry 4 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,095 F1 · balance_after: Amount is subject to adjustment pursuant to a domestic relations order. Read SEC document |
| March 03, 2009 Filed Mar 5, 2009 22:00 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 6,782 | $46.25 | $313,667.50 |
DisclosureSEC source: 0001104659-09-014711 · a4.xml · nonDerivative · entry 3 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,895 F1 · balance_after: Amount is subject to adjustment pursuant to a domestic relations order. Read SEC document |
| March 03, 2009 Filed Mar 5, 2009 22:00 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 100 | $46.28 | $4,628.00 |
DisclosureSEC source: 0001104659-09-014711 · a4.xml · nonDerivative · entry 2 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,677 F1 · balance_after: Amount is subject to adjustment pursuant to a domestic relations order. Read SEC document |
| March 03, 2009 Filed Mar 5, 2009 22:00 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 200 | $46.28 | $9,256.04 |
DisclosureSEC source: 0001104659-09-014711 · a4.xml · nonDerivative · entry 1 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,777 F1 · balance_after: Amount is subject to adjustment pursuant to a domestic relations order. Read SEC document |
| February 27, 2009 Filed Mar 4, 2009 00:41 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 5,775 | $50.58 | $292,099.50 |
DisclosureSEC source: 0001104659-09-013961 · a4.xml · nonDerivative · entry 1 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,977 F1 · balance_after: Amount is subject to adjustment pursuant to a domestic relations order. Read SEC document |
| February 20, 2009 Filed Feb 24, 2009 22:04 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 38,700 | $0.00 Strike: $54.14 | $0.00 |
DisclosureSEC source: 0001104659-09-011817 · a4.xml · derivative · entry 3 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,700 Underlying: Common shares · 38,700 shares Expires 2019-02-19 F4 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 12,900 on 02/20/2010, 12,900 on 02/20/2011, and 12,900 on 02/20/2012. Read SEC document |
| February 20, 2009 Filed Feb 24, 2009 22:04 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 27,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-09-011817 · a4.xml · nonDerivative · entry 1 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,752 F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 1996 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. F2 · balance_after: Amount is subject to adjustment pursuant to a domestic relations order. Read SEC document |
| February 17, 2009 Filed Feb 20, 2009 01:52 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 884 | $54.25 | $47,958.77 |
DisclosureSEC source: 0001104659-09-010839 · a4.xml · nonDerivative · entry 2 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,552 F1 · balance_after: Amount is subject to adjustment pursuant to a domestic relations order. Read SEC document |
| February 17, 2009 Filed Feb 20, 2009 01:52 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 2,991 | $54.94 | $164,325.54 |
DisclosureSEC source: 0001104659-09-010839 · a4.xml · nonDerivative · entry 1 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,436 F1 · balance_after: Amount is subject to adjustment pursuant to a domestic relations order. Read SEC document |
| February 05, 2009 Filed Feb 10, 2009 02:45 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 11,808 | $0.00 Strike: $56.34 | $0.00 |
DisclosureSEC source: 0001104659-09-007747 · a4.xml · derivative · entry 4 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 11,808 shares Expires 2009-02-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. F1 · balance_after: Amount is subject to adjustment pursuant to a domestic relations order. Read SEC document |
| February 05, 2009 Filed Feb 10, 2009 02:45 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 11,808 | $56.44 | $666,443.52 |
DisclosureSEC source: 0001104659-09-007747 · a4.xml · nonDerivative · entry 2 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,427 F1 · balance_after: Amount is subject to adjustment pursuant to a domestic relations order. Read SEC document |
| February 05, 2009 Filed Feb 10, 2009 02:45 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 11,808 | $56.34 | $665,262.72 |
DisclosureSEC source: 0001104659-09-007747 · a4.xml · nonDerivative · entry 1 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,235 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Amount is subject to adjustment pursuant to a domestic relations order. Read SEC document |
| February 04, 2009 Filed Feb 6, 2009 23:44 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 881 | $0.00 Strike: $53.60 | $0.00 |
DisclosureSEC source: 0001104659-09-007394 · a4.xml · derivative · entry 5 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 881 shares Expires 2009-02-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. F1 · balance_after: Amount is subject to adjustment pursuant to a domestic relations order. Read SEC document |
| February 04, 2009 Filed Feb 6, 2009 23:44 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 281 | $56.24 | $15,804.00 |
DisclosureSEC source: 0001104659-09-007394 · a4.xml · nonDerivative · entry 3 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,427 F1 · balance_after: Amount is subject to adjustment pursuant to a domestic relations order. Read SEC document |
| February 04, 2009 Filed Feb 6, 2009 23:44 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 600 | $56.25 | $33,752.40 |
DisclosureSEC source: 0001104659-09-007394 · a4.xml · nonDerivative · entry 2 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,708 F1 · balance_after: Amount is subject to adjustment pursuant to a domestic relations order. Read SEC document |
| February 04, 2009 Filed Feb 6, 2009 23:44 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 881 | $53.60 | $47,221.60 |
DisclosureSEC source: 0001104659-09-007394 · a4.xml · nonDerivative · entry 1 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,308 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Amount is subject to adjustment pursuant to a domestic relations order. Read SEC document |
| January 26, 2009 Filed Jan 27, 2009 22:31 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 1,159 | $53.90 | $62,471.26 |
DisclosureSEC source: 0001104659-09-004383 · a4.xml · nonDerivative · entry 4 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,427 Read SEC document |
| January 26, 2009 Filed Jan 27, 2009 22:31 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 281 | $53.89 | $15,143.65 |
DisclosureSEC source: 0001104659-09-004383 · a4.xml · nonDerivative · entry 3 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,586 Read SEC document |
| January 26, 2009 Filed Jan 27, 2009 22:31 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 200 | $53.89 | $10,778.80 |
DisclosureSEC source: 0001104659-09-004383 · a4.xml · nonDerivative · entry 2 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,867 Read SEC document |
| January 26, 2009 Filed Jan 27, 2009 22:31 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 860 | $53.91 | $46,363.55 |
DisclosureSEC source: 0001104659-09-004383 · a4.xml · nonDerivative · entry 1 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,067 Read SEC document |
| September 16, 2008 Filed Sep 18, 2008 21:01 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 3,900 | $58.92 | $229,795.80 |
DisclosureSEC source: 0001104659-08-059453 · a4.xml · nonDerivative · entry 3 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,927 Read SEC document |
| September 16, 2008 Filed Sep 18, 2008 21:01 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 300 | $58.91 | $17,673.00 |
DisclosureSEC source: 0001104659-08-059453 · a4.xml · nonDerivative · entry 2 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,827 Read SEC document |
| September 16, 2008 Filed Sep 18, 2008 21:01 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 800 | $58.93 | $47,145.60 |
DisclosureSEC source: 0001104659-08-059453 · a4.xml · nonDerivative · entry 1 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,127 Read SEC document |
| July 09, 2008 Filed Jul 11, 2008 22:04 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOptions (right to buy) · Derivative | 10,050 | $0.00 Strike: $57.37 | $0.00 |
DisclosureSEC source: 0001104659-08-045352 · a4.xml · derivative · entry 5 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,050 Underlying: Common shares · 10,050 shares Expires 2011-02-08 F2 · security: Employee stock option, including replacement option feature, granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| July 09, 2008 Filed Jul 11, 2008 22:04 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOptions (right to buy) · Derivative | 11,390 | $0.00 Strike: $45.45 | $0.00 |
DisclosureSEC source: 0001104659-08-045352 · a4.xml · derivative · entry 4 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,812 Underlying: Common shares · 11,390 shares Expires 2011-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option, including replacement option feature, granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| July 09, 2008 Filed Jul 11, 2008 22:04 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 10,050 | $57.37 | $576,568.50 |
DisclosureSEC source: 0001104659-08-045352 · a4.xml · nonDerivative · entry 2 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,927 Read SEC document |
| July 09, 2008 Filed Jul 11, 2008 22:04 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 11,390 | $45.45 | $517,661.83 |
DisclosureSEC source: 0001104659-08-045352 · a4.xml · nonDerivative · entry 1 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,977 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 01, 2008 Filed Jun 3, 2008 22:19 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 749 | $56.35 | $42,206.15 |
DisclosureSEC source: 0001104659-08-037606 · a4.xml · nonDerivative · entry 1 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,587 Read SEC document |
| February 29, 2008 Filed Mar 5, 2008 01:10 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 2,938 | $54.22 | $159,298.36 |
DisclosureSEC source: 0001104659-08-015211 · a4.xml · nonDerivative · entry 1 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,336 Read SEC document |
| February 22, 2008 Filed Feb 26, 2008 21:12 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 3,284 | $0.00 Strike: $54.86 | $0.00 |
DisclosureSEC source: 0001104659-08-012901 · a4.xml · derivative · entry 5 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,284 Underlying: Common shares · 3,284 shares Expires 2010-02-10 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| February 22, 2008 Filed Feb 26, 2008 21:12 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 3,731 | $0.00 Strike: $43.25 | $0.00 |
DisclosureSEC source: 0001104659-08-012901 · a4.xml · derivative · entry 4 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 3,731 shares Expires 2010-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| February 22, 2008 Filed Feb 26, 2008 21:12 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 3,284 | $54.86 | $180,160.24 |
DisclosureSEC source: 0001104659-08-012901 · a4.xml · nonDerivative · entry 2 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,274 Read SEC document |
| February 22, 2008 Filed Feb 26, 2008 21:12 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 3,731 | $43.25 | $161,365.75 |
DisclosureSEC source: 0001104659-08-012901 · a4.xml · nonDerivative · entry 1 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,558 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 19, 2008 Filed Feb 20, 2008 23:26 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 284 | $56.08 | $15,927.29 |
DisclosureSEC source: 0001104659-08-011826 · a4.xml · nonDerivative · entry 5 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,827 Read SEC document |
| February 19, 2008 Filed Feb 20, 2008 23:26 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 600 | $56.08 | $33,648.00 |
DisclosureSEC source: 0001104659-08-011826 · a4.xml · nonDerivative · entry 4 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,111 Read SEC document |
| February 18, 2008 Filed Feb 20, 2008 23:26 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 591 | $55.55 | $32,830.05 |
DisclosureSEC source: 0001104659-08-011826 · a4.xml · nonDerivative · entry 3 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,711 Read SEC document |
| February 17, 2008 Filed Feb 20, 2008 23:26 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 3,719 | $55.55 | $206,590.45 |
DisclosureSEC source: 0001104659-08-011826 · a4.xml · nonDerivative · entry 2 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,302 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.